Sign in

CIK 0001659617

  • Non-accelerated filer
  • Smaller reporting company

Moleculin Biotech, Inc.

Sign in to watch
Ticker
MBRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474671997
Phone
+1 713-300-5160
Business address
5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, 77007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 Cermak Elizabeth Director Grant or award · Stock Options (right to buy) +4,000 4,331
2026-11-17 Climaco John M Director Grant or award · Stock Options (right to buy) +4,000 4,334
2026-11-17 CANNON MICHAEL D Director Grant or award · Stock Options (right to buy) +4,000 4,334
2026-11-17 George Robert E. Director Grant or award · Stock Options (right to buy) +4,000 4,334
2026-11-16 Foster Jonathan P. Chief Financial Officer Exercise or conversion +362 20,595
2026-11-16 Foster Jonathan P. Chief Financial Officer Shares withheld for taxes −89 $7.14 $635 20,506
2026-11-16 Foster Jonathan P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −362 70,492
2026-11-16 KLEMP WALTER V CEO and President Exercise or conversion +577 36,686
2026-11-16 KLEMP WALTER V CEO and President Shares withheld for taxes −141 $7.41 $1K 36,545
2026-11-16 KLEMP WALTER V CEO and President Exercise or conversion · Restricted Stock Units −577 126,838
2026-11-04 PICKER DONALD H Chief Science Officer Exercise or conversion +17 8,722
2026-11-04 PICKER DONALD H Chief Science Officer Shares withheld for taxes −4 $8.46 $34 8,718
2026-11-04 PICKER DONALD H Chief Science Officer Exercise or conversion · Restricted Stock Units −18 39,474
2026-11-04 Foster Jonathan P. Chief Financial Officer Exercise or conversion +41 20,301
2026-11-04 Foster Jonathan P. Chief Financial Officer Shares withheld for taxes −10 $8.46 $85 20,291
2026-11-04 Foster Jonathan P. Chief Financial Officer Exercise or conversion · Restricted Stock Units −41 70,854
2026-11-04 KLEMP WALTER V CEO and President Exercise or conversion +57 36,217
2026-11-04 KLEMP WALTER V CEO and President Shares withheld for taxes −14 $8.46 $118 36,203
2026-11-04 KLEMP WALTER V CEO and President Exercise or conversion · Restricted Stock Units −57 127,415
2026-10-15 PICKER DONALD H Chief Science Officer Grant or award · Stock Options (right to buy) +250,000 789,595

Page 1 of 14 · 279 trades